DTE

27.81

-1%↓

IBE

19.735

+1.41%↑

ORA

17.515

-0.48%↓

RWE

56.2

-0.67%↓

ELE

36.54

+0.86%↑

DTE

27.81

-1%↓

IBE

19.735

+1.41%↑

ORA

17.515

-0.48%↓

RWE

56.2

-0.67%↓

ELE

36.54

+0.86%↑

DTE

27.81

-1%↓

IBE

19.735

+1.41%↑

ORA

17.515

-0.48%↓

RWE

56.2

-0.67%↓

ELE

36.54

+0.86%↑

DTE

27.81

-1%↓

IBE

19.735

+1.41%↑

ORA

17.515

-0.48%↓

RWE

56.2

-0.67%↓

ELE

36.54

+0.86%↑

DTE

27.81

-1%↓

IBE

19.735

+1.41%↑

ORA

17.515

-0.48%↓

RWE

56.2

-0.67%↓

ELE

36.54

+0.86%↑

Home・Stock List・STRATEC Biomedical AG

STRATEC Biomedical AG

Closed

16.72 1.46

Buy Sell

Overview

Share price change

24h

Current

Min

Max

16.9

Key metrics
By Trading Economics
Income	2.6M -1.7M
Sales	-22M 53M
P/E Sector Avg	14.63 30.765
EPS	-0.357
Dividend yield	3.39
Profit margin	-3.206
Employees	1,343
EBITDA	-6.7M 4.1M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+69.49% upside

Dividends
By Dow Jones
Dividend yield Sector Avg	3.39% 3.24%
Next Earnings	14 Aug 2026

Market Stats
By TradingEconomics
Market Cap	-6.1M 208M
Previous open	15.26
Previous close	16.72

STRATEC Biomedical AG Chart

Past performance is not a reliable indicator of future results.

Related News

8 Jul 2025, 17:24 UTC

Market Talk

Election, Dollar Seen as Potential Headwinds for Ibovespa -- Market Talk

Peer Comparison

Price change

STRATEC Biomedical AG Forecast

Price Target

By TipRanks

69.49% upside

12 Months Forecast

Average 28 EUR 69.49%

High 37 EUR

Low 21 EUR

Based on 3 Wall Street analysts offering 12 month price targets forSTRATEC Biomedical AG - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

3 ratings

Buy

Hold

Sell

Based on 3 analysts giving stock ratings to STRATEC Biomedical AG - Dist in the past 3 months.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About STRATEC Biomedical AG

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.